Alibeik et al., 2012 - Google Patents
Modification of polyurethane with polyethylene glycol–corn trypsin inhibitor for inhibition of factor Xlla in blood contactAlibeik et al., 2012
- Document ID
- 6707563203034476194
- Author
- Alibeik S
- Zhu S
- Yau J
- Weitz J
- Brash J
- Publication year
- Publication venue
- Journal of Biomaterials Science, Polymer Edition
External Links
Snippet
In previous work using gold as a model substrate, we showed that modification of surfaces with poly (ethylene glycol)(PEG) and corn trypsin inhibitor (CTI) rendered them protein resistant and inhibitory against activated factor XII. Sequential attachment of PEG followed …
- 229920001223 polyethylene glycol 0 title abstract description 64
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lampsas et al. | Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment | |
| Alibeik et al. | Modification of polyurethane with polyethylene glycol–corn trypsin inhibitor for inhibition of factor Xlla in blood contact | |
| Selmeci | Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? | |
| Feistritzer et al. | Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells | |
| Makogonenko et al. | Interaction of fibrin (ogen) with fibronectin: further characterization and localization of the fibronectin-binding site | |
| Maitz et al. | Bio-responsive polymer hydrogels homeostatically regulate blood coagulation | |
| Li et al. | Lysine-PEG-modified polyurethane as a fibrinolytic surface: effect of PEG chain length on protein interactions, platelet interactions and clot lysis | |
| Dunn et al. | Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus | |
| Koizume et al. | Tissue factor–factor VII complex as a key regulator of ovarian cancer phenotypes | |
| Li et al. | Thrombosis‐responsive thrombolytic coating based on thrombin‐degradable tissue plasminogen activator (T‐Pa) nanocapsules | |
| Marsh et al. | Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry | |
| Moaddel et al. | Interactions of Human Fibrinogens with Factor XIII: Roles of Calcium and the γ ‘Peptide | |
| Palma et al. | Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen | |
| Pawlak et al. | Chemical modification of polymer ion‐selective membrane electrode surfaces | |
| Jolly et al. | Electro-engineered polymeric films for the development of sensitive aptasensors for prostate cancer marker detection | |
| Memtsas et al. | Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis | |
| De Cristofaro et al. | Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib | |
| van Pel et al. | Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization | |
| Dharmawardana et al. | Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases | |
| Leung et al. | Surface modification of polydimethylsiloxane with a covalent antithrombin–heparin complex to prevent thrombosis | |
| Rodriguez | Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis? | |
| Kang et al. | Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots | |
| Siebenlist et al. | Evidence for Intramolecular Cross-Linked Aα⊙ γ Chain Heterodimers in Plasma Fibrinogen | |
| Nencini et al. | Fibrinogen oxidation and thrombosis: shaping structure and function | |
| Kwon et al. | Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma |